Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Evidence for Evolution02:55

The Evidence for Evolution

48.0K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

414
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
414
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

364
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
364
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.3K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

1.4K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
1.4K
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

718
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
718

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.

Allergy·2026
Same author

Pathophysiology, prevention, and management of coronary microvascular obstruction.

European heart journal·2026
Same author

Liquid-liquid phase separation as a tool to compartmentalize stimuli-responsive cargoes within protocell models.

Journal of colloid and interface science·2026
Same author

Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.

European heart journal. Acute cardiovascular care·2026
Same author

Percutaneous Left Atrial Appendage Closure: Current Evidence and Procedural Insights.

Reviews in cardiovascular medicine·2026
Same author

Galaxy single-cell & spatial omics community update: Navigating new frontiers in 2025.

Cell genomics·2025

Related Experiment Video

Updated: Jan 29, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.4K

Excimer Laser Coronary Atherectomy: Current Evidence, Clinical Applications, and Future Directions.

Mohsen Mohandes1, Alberto Pernigotti1, Mauricio Torres1

  • 1Interventional Cardiology Unit, Cardiology Division, Joan XXIII University Hospital, Pere Virgili Health Research Institute (IISPV), 43005 Tarragona, Spain.

Journal of Clinical Medicine
|January 28, 2026
PubMed
Summary

Excimer Laser Coronary Atherectomy (ELCA) effectively treats complex coronary lesions by ablating plaque. Refinements enhance its use in percutaneous coronary intervention for improved outcomes.

Keywords:
ELCA (excimer laser coronary atherectomy)HTB (high thrombus burden)ISR (in-stent restenosis)PCI (percutaneous coronary intervention)

More Related Videos

Transcranial Direct Current Stimulation tDCS in Mice
11:54

Transcranial Direct Current Stimulation tDCS in Mice

Published on: September 23, 2018

15.2K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Related Experiment Videos

Last Updated: Jan 29, 2026

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure
08:20

Simultaneous Application of Transcranial Direct Current Stimulation during Virtual Reality Exposure

Published on: January 18, 2021

4.4K
Transcranial Direct Current Stimulation tDCS in Mice
11:54

Transcranial Direct Current Stimulation tDCS in Mice

Published on: September 23, 2018

15.2K
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
12:00

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

15.9K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Laser Medicine

Background:

  • Percutaneous coronary intervention (PCI) faces challenges with complex coronary anatomy.
  • Excimer Laser Coronary Atherectomy (ELCA) offers a precise method for plaque ablation.
  • Technical advancements have improved ELCA's safety and efficacy.

Purpose of the Study:

  • To review the principles, procedures, and clinical evidence for ELCA.
  • To highlight ELCA's role in managing complex coronary lesions.
  • To assess ELCA's impact on PCI outcomes.

Main Methods:

  • Review of fundamental excimer laser-tissue interactions.
  • Discussion of ELCA equipment and procedural considerations.
  • Examination of clinical data from observational studies and registries.

Main Results:

  • ELCA enhances device crossability and restores coronary flow, reducing embolization in thrombus-rich lesions.
  • It facilitates plaque modification and improves success in uncrossable lesions, including chronic total occlusions.
  • ELCA effectively treats stent underexpansion, improving minimal stent area.

Conclusions:

  • ELCA is a valuable adjunctive tool for complex PCI, addressing challenges like underexpansion and uncrossable lesions.
  • Its precise ablation mechanism minimizes thermal injury, making it suitable for diverse plaque types.
  • Ongoing research will further define ELCA's optimal application in interventional cardiology.